The Journal of Immunology, Vol 155, Issue 9 4231-4235, Copyright © 1995 by American Association of Immunologists

ARTICLES

Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo

Y Nakata, K Matsuda, A Uzawa, M Nomura, M Akashi and G Suzuki
Division of Clinical Research and Radiation Health, National Institute of Radiologic Sciences, Chiba, Japan.

Peripheral tolerance is important to prevent autoimmunity of T cells against tissue-specific autoantigens in peripheral organs. In certain pathologic situations, peripheral tolerance breaks for unknown reasons and autoimmune diseases occur. Anergy is one of the mechanisms of peripheral tolerance that down-modulates IL-2 synthesis and IL-4 responsiveness by helper T cell clones. In this report, we utilized a model system in which V beta 8+ CD4 T cells were anergized by administration of high doses of Staphylococcus enterotoxin B (SEB) in vivo and investigated an effect of recombinant human (rh) IL-1 on the tolerance induction. RhIL-1 was used because of its ability to induce IL-4 responsiveness in T cells. When rhIL-1 was administered within 24 h after SEB inoculation, the cytokine interfered with tolerance induction; V beta 8+CD4 T cells from mice that had been treated with both SEB and IL-1 proliferated in response to SEB and produced IL-2, IL- 4, and IFN-gamma upon TCR/CD28 cross-linking. Delayed administration of rhIL-1 by 48 h failed to do this; T cells did not proliferate in response to SEB, but they retained an ability to produce IL-4 upon TCR/CD28 cross-linking. Administration of rhIL-1 induced better proliferation of V beta 8+CD4 T cells in response to SEB in vivo but did not prevent cell death after proliferation. These results suggest a potential role of inflammatory cytokine IL-1 in the course of autoimmunity via interference with tolerance.

This article has been cited by other articles:

				J. R. Maxwell, C. Ruby, N. I. Kerkvliet, and A. T. Vella Contrasting the Roles of Costimulation and the Natural Adjuvant Lipopolysaccharide During the Induction of T Cell Immunity J. Immunol., May 1, 2002; 168(9): 4372 - 4381. [Abstract] [Full Text] [PDF]

				Y. Nakata, A. Uzawa, and G. Suzuki Control of CD4 T cell fate by antigen re-stimulation with or without CTLA-4 engagement 24 h after priming Int. Immunol., April 1, 2000; 12(4): 459 - 466. [Abstract] [Full Text] [PDF]

				H. Kawasaki1, Y. Nakata, G. Suzuki, K. Chihara, T. Tokuhisa, and S. Shiozawa Increased c-Fos/activator protein-1 confers resistance against anergy induction on antigen-specific T cell Int. Immunol., December 1, 1999; 11(12): 1873 - 1880. [Abstract] [Full Text] [PDF]

				S. Saijo, M. Kotani, K. Habu, C. Ishitsuka, H. Yamamoto, T. Sekiguchi, and Y. Iwakura Bone Marrow-Derived Cells Are Responsible for the Development of Autoimmune Arthritis in Human T Cell Leukemia Virus Type I-Transgenic Mice and Those of Normal Mice Can Suppress the Disease J. Immunol., November 15, 1999; 163(10): 5700 - 5707. [Abstract] [Full Text] [PDF]

				Y. Iwakura, K. Itagaki, C. Ishitsuka, Y. Yamasaki, A. Matsuzawa, S. Yonehara, S. Karasawa, S. Ueda, and S. Saijo The Development of Autoimmune Inflammatory Arthropathy in Mice Transgenic for the Human T Cell Leukemia Virus Type-1 env-pX Region Is Not Dependent on H-2 Haplotypes and Modified by the Expression Levels of Fas Antigen J. Immunol., December 15, 1998; 161(12): 6592 - 6598. [Abstract] [Full Text] [PDF]